Prior to joining the company, Mr. Reasons served as vice president of finance, as well as vice president of risk management and general auditor, at Cephalon, Inc. Following the acquisition of Cephalon by Teva, he served briefly as the vice president of finance at Teva.
“Following a nationwide search, Bryan Reasons was selected as the best candidate to fill the CFO role,” said Larry Hsu, Ph.D., president and chief executive officer, Impax Laboratories. “He has a breadth of knowledge across accounting and finance, combined with extensive merger and acquisition experience within the pharmaceutical industry. In less than two years, we have significantly transformed Impax’s leadership team across a number of functions as we focus on executing our growth strategy.”